Kyle Crockett - Feb 14, 2025 Form 4 Insider Report for CARRIER GLOBAL Corp (CARR)

Role: VP, Controller & CAO
Signature: /s/ Erin O'Neal as Attorney-in-Fact
Stock symbol: CARR
Transactions as of: Feb 14, 2025
Transactions value $: -$4,207,923
Form type: 4
Date filed: 2/19/2025, 05:51 PM
Previous filing: Feb 10, 2025
Next filing: Aug 7, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CARR	Common Stock	Options Exercise	$941K	+24.5K	+318.85%	$38.33	32.2K	Feb 14, 2025	Direct	F1
transaction	CARR	Common Stock	Options Exercise	$1M	+21.1K	+65.36%	$47.51	53.3K	Feb 14, 2025	Direct	F1
transaction	CARR	Common Stock	Tax liability	-$941K	-14.4K	-27.08%	$65.17	38.9K	Feb 14, 2025	Direct
transaction	CARR	Common Stock	Tax liability	-$1M	-15.4K	-39.51%	$65.17	23.5K	Feb 14, 2025	Direct
transaction	CARR	Common Stock	Sale	-$1.23M	-18.9K	-80.56%	$65.18	4.57K	Feb 14, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CARR	Stock Appreciation Right	Options Exercise	-$1.37M	-21.1K	-100%	$65.17	0	Feb 14, 2025	Common Stock	21.1K	$47.51	Direct
transaction	CARR	Stock Appreciation Right	Options Exercise	-$1.6M	-24.5K	-100%	$65.17	0	Feb 14, 2025	Common Stock	24.5K	$38.33	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
F2	The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $65.1705 to $65.185 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $65.1705 to $65.185 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.